Change - Announcement of Cessation::Resignation of Chief Operating Officer - Ms Wang Qingyin

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
09-Jul-2021 18:17:54
Status
New
Announcement Sub Title
Resignation of Chief Operating Officer - Ms Wang Qingyin
Announcement Reference
SG210709OTHR0G76
Submitted By (Co./ Ind. Name)
Yee Pinh Jeremy
Designation
Non-Executive Non-Independent Chairman
Description (Please provide a detailed description of the event in the box below)
Resignation of Ms Wang Qingyin as the Chief Operating Officer of Biolidics Limited (the "Company").

This announcement has been prepared by the Company and has been reviewed by United Overseas Bank Limited (the "Sponsor") for compliance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lim Hoon Khiat, Director, Equity Capital Markets, who can be contacted at 80 Raffles Place, #03-03 UOB Plaza 1, Singapore 048624, telephone: +65 6533 9898.

Additional Details

Name Of Person
Wang Qingyin
Age
49
Is effective date of cessation known?
Yes
If yes, please provide the date
03/09/2021
Detailed Reason (s) for cessation
Ms Wang Qingyin will be moving back to the People's Republic of China to fulfil family obligations.

The Sponsor, after interviewing Ms Wang Qingyin, is satisfied that, save as disclosed in this announcement, there are no material reasons for the cessation of Ms Wang Qingyin as the Chief Operating Officer of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
01/08/2019
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
3
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Operating Officer
Role and responsibilities
Executive. Ms Wang Qingyin is responsible for overseeing the operations of the Company and its subsidiaries.

Ms Wang Qingyin's responsibility of overseeing the operations of the Company and its subsidiaries will be undertaken by the rest of the management team after her effective date of cessation.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
598,700 shares in the Company
Past (for the last 5 years)
Biomedics Laboratory Pte Ltd
Present
Nil